Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

edoxaban × 30 days × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 1 Neoplasms 1 Embolism 1

Interventions

Specimen Handling 352 Magnetic Resonance Spectroscopy 286 pembrolizumab 285 Biopsy 222 Carboplatin 199 Cyclophosphamide 182 Cisplatin 164 Paclitaxel 148 Nivolumab 131 Gemcitabine 126 Radiotherapy 119 venetoclax 110 Dexamethasone 106 Bevacizumab 104 fludarabine 93 Pemetrexed 85 Oxaliplatin 84 Fluorouracil 84 Rituximab 81 durvalumab 80 Docetaxel 79 Radiation 77 Doxorubicin 77 atezolizumab 76 Lenalidomide 73 Prednisone 69 X-Rays 63 Ipilimumab 62 Capecitabine 62 Standard of Care 61

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04618913 2026-03-12

VICTORIE

Pfizer

Active not recruiting

Classical hematology

Embolism, Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡